Thrombophilia and Women's Health: An Overview

Obstetrics and Gynecology Clinics of North America

Volumn 33, Issue 3, 2006, Pages 347-356

  Blickstein, Isaac ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; EMBRYO DEATH; FEMALE; FETUS WASTAGE; GENETIC DISORDER; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE GROWTH RETARDATION; ORAL CONTRACEPTION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUERPERIUM; REVIEW; SCREENING TEST; SOLUTIO PLACENTAE; THROMBOGENESIS; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

ARTERIES; ETHNIC GROUPS; EVIDENCE-BASED MEDICINE; FACTOR V; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOSIS; WOMEN'S HEALTH;

EID: 33748299050     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2006.05.003     Document Type: Review

References (14)

1. Owen Jr. C.A. A history of blood coagulation. In: Nichols W.L., and Walter Bowie E.J. (Eds) (2001), Mayo Foundation, Rochester, MN
2. Jacques L.B. The Howell theory of blood coagulation: a record of the pernicious effects of a false theory. Can Bull Med Hist 5 (1988) 143-165
3. Aristotle. On the generation of animals. Book 1. Translated by Platt A. Availabe at: www.mlahanas.de/Greeks/Aristotle/OnTheGenerationOfAnimals. Accessed February 1, 2006.
4. McFadden P.M., and Ochsner J.L. A history of the diagnosis and treatment of venous thrombosis and pulmonary embolism. Ochsner J 4 (2002) 9-13
5. Blickstein D., and Blickstein I. The risk of fetal loss associated with Warfarin anticoagulation. Int J Gynaecol Obstet 78 (2002) 221-225
6. Vandenbroucke J.P., Koster P., Briet E., et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344 (1994) 1453-1457
7. Reich L.M., Bower M., and Key N.S. Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med 5 (2003) 133-143
8. Rees D.C., Cox M., and Clegg J.B. World distribution of factor V Leiden. Lancet 346 (1995) 1133-1134
9. Ridker P.M., Miletich J.P., Hennekens C.H., et al. Ethnic distribution of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. JAMA 277 (1997) 1305-1307
10. Sibai B.M. Thrombophilias and adverse outcomes of pregnancy: what should a clinician do?. N Engl J Med 340 (1999) 50-52
11. Said J., and Dekker G. Pre-eclampsia and thrombophilia. Best Pract Res Clin Obstet Gynaecol 17 (2003) 441-458
12. Greer I.A., and Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106 (2005) 401-407
13. Cook D.J., Guyatt G.H., Laupacis A., et al. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 108 (1995) 227S-230S
14. Bates S.M., Greer I.A., Hirsh J., et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 627S-644S